Replies to post #49574 on Ayala Pharmaceuticals Inc (ADXS)

[trading_cyclist]

Perhaps "done" is the right word, but in the works. It took over a year to sell Ariad, so it may well be longer for us with ADXS. However, Ariad got VERY quiet at the end, much like ADXS is now.

Just idle speculation, and perhaps wishful thinking on my part. Nothing more.

TC

[equaloppforall]

Well, it usually takes a while to stitch up a buyout deal. Also, other small biotechs were conspicuously silent for long durations before they were sold. The length of time that ADXS has been silent (other than to communicate routine, formality laden updates) is not just unusual, it is abnormal. One also has to consider Lombardo's prior track record as a CEO and his refusal/failure to let go of the interim prefix even: after 7 months at the helm.

By no means am I saying a buyout is imminent at this time, but I think the odds are much higher now than ever before. As I said in my previous post, I would be happy if a buyout is held off until one or more significant milestones are met.